Compare WY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WY | SNN |
|---|---|---|
| Founded | 1900 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2B | 14.1B |
| IPO Year | N/A | 1999 |
| Metric | WY | SNN |
|---|---|---|
| Price | $25.75 | $34.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | $28.57 | ★ $32.83 |
| AVG Volume (30 Days) | ★ 7.9M | 979.9K |
| Earning Date | 01-29-2026 | 02-24-2026 |
| Dividend Yield | ★ 3.24% | 2.17% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | 0.45 | ★ 0.56 |
| Revenue | ★ $6,905,000,000.00 | $5,944,000,000.00 |
| Revenue This Year | N/A | $7.71 |
| Revenue Next Year | $2.73 | $5.23 |
| P/E Ratio | ★ $57.91 | $60.31 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | $21.16 | $23.91 |
| 52 Week High | $31.66 | $38.79 |
| Indicator | WY | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 55.80 | 58.04 |
| Support Level | $26.46 | $33.29 |
| Resistance Level | $26.38 | $34.27 |
| Average True Range (ATR) | 0.70 | 0.58 |
| MACD | -0.15 | 0.13 |
| Stochastic Oscillator | 39.97 | 88.54 |
Weyerhaeuser ranks among the world's largest forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.